Sensome, formerly Instent, a company developing a micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, Plaiseau, announced that it has completed its €4.7m seed round to bring its first product to clinical trials.
Sensome’s sensing technology is designed to be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.
Sensome’s first product integrates its proprietary technology with a guidewire for the treatment of ischaemic stroke. The company’s connected stroke guidewire is designed to help select the fastest device to reopen the vessel for each patient.
